Skip to main content

iTeos Therapeutics, Inc.

ITOSDelisted Aug 29, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001808865

iTeos Therapeutics, Inc. was delisted on Aug 29, 2025; its insiders filed their last Form 4 on Aug 29, 2025; 137 institutions reported holding it in 13F filings for Q2 2025, worth $377.0M in total; no superinvestor held it.

Holders of 5% or more of ITOS

Holders whose latest Schedule 13D or 13G filing reports 5% or more of iTeos Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of ITOS
HolderLatest formStakeChangeFirst filedLatest filingFiling
Tang Capital Management LLC13D/A100.00%10.0K shares+90.01 ppfrom 9.99%Sep 30, 20246 filingsSep 3, 2025SEC
EcoR1 Capital, LLC13D27.90%10.7M shares+13.00 ppfrom 14.90%Feb 16, 20245 filingsMay 16, 2025SEC
BlackRock Portfolio Management LLC13G6.10%2.33M sharesNewApr 15, 20251 filingApr 15, 2025SEC
BlackRock, Inc.13G/A5.70%2.18M shares–Oct 21, 20243 filingsApr 23, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

52 Schedule 13D and 13G filings on iTeos Therapeutics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on ITOS
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 14, 20254:03 PM ETRidgeback Capital Investments L.P.and 2 others13G/A0.00%0 shares−5.10 ppfrom 5.10%Below 5%Sep 30, 2025SEC
Sep 3, 20254:15 PM ETTang Capital Management LLCand 7 others13D/A100.00%10.0K shares+90.01 ppfrom 9.99%Aug 29, 2025SEC
Aug 14, 20254:03 PM ETBiotechnology Value Fund L Pand 9 others13G/A0.00%0 shares−8.10 ppfrom 8.10%Below 5%Jun 30, 2025SEC
Jul 25, 20254:03 PM ETRidgeback Capital Investments L.P.and 2 others13G5.10%1.94M shares+1.30 ppfrom 3.80%Jul 21, 2025SEC
Jul 22, 20254:31 PM ETTang Capital Management LLCand 6 others13D/A9.99%3.83M shares0.00 ppfrom 9.99%Jul 18, 2025SEC
Jun 12, 20254:27 PM ETTang Capital Management LLCand 6 others13D9.99%3.83M shares0.00 ppfrom 9.99%Jun 11, 2025SEC
Jun 4, 20254:00 PM ETRidgeback Capital Investments L.P.and 2 others13G3.80%1.44M sharesNewBelow 5%May 28, 2025SEC
May 19, 20255:46 PM ETRa Capital Management, L.P.and 3 others13D/A4.90%2.13M shares−5.00 ppfrom 9.90%Below 5%May 15, 2025SEC
May 16, 20257:22 PM ETEcoR1 Capital, LLCand 2 others13D27.90%10.7M shares+13.00 ppfrom 14.90%May 15, 2025SEC
May 15, 20255:30 PM ETMPM BioVentures 2014, L.P.and 15 others13D/A4.70%1.80M shares–Below 5%May 13, 2025SEC
May 15, 20254:35 PM ETBiotechnology Value Fund L Pand 9 others13G/A8.10%3.08M shares–Mar 31, 2025SEC
May 15, 20254:15 PM ETTang Capital Management LLCand 5 others13G9.99%3.83M shares+9.39 ppfrom 0.60%May 13, 2025SEC
May 14, 20256:34 PM ETRa Capital Management, L.P.and 3 others13D/A9.90%4.16M shares–May 12, 2025SEC
May 13, 20257:10 PM ETEcoR1 Capital, LLCand 2 others13G/A14.90%5.73M shares+8.00 ppfrom 6.90%May 13, 2025SEC
May 8, 20257:43 PM ETEcoR1 Capital, LLCand 2 others13G6.90%2.66M shares–May 1, 2025SEC
Apr 23, 20258:57 PM ETBlackRock, Inc.13G/A5.70%2.18M shares–Mar 31, 2025SEC
Apr 15, 20255:04 PM ETBlackRock Portfolio Management LLC13G6.10%2.33M sharesNewMar 31, 2025SEC
Feb 14, 20254:00 PM ETTang Capital Management LLCand 4 others13G/A0.60%221.7K shares–Below 5%Dec 31, 2024SEC
Nov 21, 2024Biotechnology Value Fund L P13GOld format–––SEC
Nov 18, 2024Boxer Capital Management, LLC13D/AOld format–––SEC
Nov 18, 2024Boxer Capital Management, LLC13D/AOld format–––SEC
Nov 14, 2024EcoR1 Capital, LLC13G/AOld format–––SEC
Nov 8, 2024BlackRock, Inc.13G/AOld format–––SEC
Oct 21, 2024BlackRock, Inc.13G/AOld format–––SEC
Oct 15, 2024Boxer Capital, LLC13D/AOld format–––SEC
Oct 15, 2024Boxer Asset Management Inc.13D/AOld format–––SEC
Sep 30, 2024Tang Capital Management LLC13GOld format–New–SEC
May 14, 2024Ra Capital Management, L.P.13D/AOld format–––SEC
May 14, 2024Boxer Capital, LLC13D/AOld format–––SEC
Feb 16, 2024EcoR1 Capital, LLC13GOld format–New–SEC
Feb 14, 2024Biotechnology Value Fund L P13G/AOld format–––SEC
Feb 13, 2024Vanguard Group Inc13G/AOld format–––SEC
Jan 23, 20244:13 PM ETBlackRock Inc.13G/AOld format–––SEC
Jan 9, 2024Millennium Management LLC13G/AOld format–––SEC
Oct 24, 2023Millennium Management LLC13GOld format–New–SEC
Feb 14, 2023Biotechnology Value Fund L P13G/AOld format–––SEC
Feb 14, 2023RTW Investments, LP13G/AOld format–––SEC
Feb 9, 2023Vanguard Group Inc13GOld format–New–SEC
Jan 26, 20238:52 AM ETBlackRock Inc.13G/AOld format–––SEC
Jan 20, 20235:17 PM ETBlackRock Inc.13G/AOld format–––SEC
Jul 8, 20224:56 PM ETBlackRock Inc.13GOld format–New–SEC
May 11, 2022Boxer Capital, LLC13D/AOld format–––SEC
May 2, 2022Biotechnology Value Fund L P13GOld format–New–SEC
Mar 21, 2022Boxer Capital, LLC13D/AOld format–––SEC
Feb 14, 2022RTW Investments, LP13G/AOld format–––SEC
Feb 10, 2022Janus Henderson Group PLC13G/AOld format–––SEC
Jan 6, 2022Boxer Capital, LLC13D/AOld format–––SEC
Dec 10, 2021MPM BioVentures 2014, L.P.13D/AOld format–––SEC
Oct 19, 2021MPM BioVentures 2014, L.P.13D/AOld format–––SEC
Sep 21, 2021MPM BioVentures 2014, L.P.13D/AOld format–––SEC

Form 144: proposed insider sales

9 notices from officers, directors and other affiliates planning to sell iTeos Therapeutics, Inc. shares, newest first.

Form 144 notices for ITOS
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Jun 10, 20254:19 PM ETDetheux MichelOfficer52.3K$523.9KJun 10, 202510b5-1UBS Financial Services IncSEC
Jun 9, 20254:12 PM ETDetheux MichelOfficer52.3K$531.7KJun 9, 202510b5-1UBS Financial Services IncSEC
Jun 6, 20254:11 PM ETDetheux MichelOfficer52.3K$532.8KJun 6, 202510b5-1UBS Financial Services IncSEC
Jun 6, 20254:09 PM ETDavid L HallalDirector38.2K$391.5KJun 6, 202510b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Jun 5, 20254:27 PM ETDavid L HallalDirector38.2K$388.1KJun 5, 202510b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Jun 5, 20254:10 PM ETDetheux MichelOfficer52.3K$534.3KJun 5, 202510b5-1UBS Financial Services IncSEC
Jun 4, 20254:03 PM ETDetheux MichelOfficer · President and CEO52.3K$526.0KJun 4, 202510b5-1UBS Financial Services IncSEC
Jun 4, 20254:03 PM ETDavid L HallalDirector38.2K$384.8KJun 4, 202510b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Aug 23, 20239:35 PM ETBoxer Capital, LLCSeller's CEO is Director of Issuer350.0K$4.11MAug 23, 2023Bank of America, N.A.SEC